HomeAbout UsContact UsPhone Number
The Thomson Corporation
Financial
Healthcare
Learning
Legal
News and Business Info
Scientific
Tax and Accounting
Advanced Search
Products & ServicesOnline CMEHot TopicsSupport My CartCHECKOUT
Products & Services
Online CME
AHC Media Interactive Audio Conferences
AHC Media eLearning
FREE Online Newsletters
Activate Your Newsletter Subscription
Hot Topics
Support

Home > Products & Services
products_and_services

BioWorld Week

Order Now!Current subscriber access -- click here!

BioWorld Week is the weekly chronicle of biotech news as reported in BioWorld Today. This abridged intelligence service, usually 5 pages, is faxed to you every Monday morning by 8 a.m. In addition to the news featured in BioWorld Today, BioWorld Week also offers the following:

  • Feature Story: Concise coverage of the week’s most important biotech news events
  • News From the Lab: Scientific breakthroughs and technological updates from key biotech labs worldwide
  • Market Watch: A three-month overview of industry averages from the CBOE and AMEX biotech indices
  • Looking Ahead: A convenient calendar of upcoming biotech seminars and conferences

A one-year subscription to BioWorld Week covering 52 issues is $949.

Order Now!Current subscriber access -- click here!

Back to top


BIOWORLD WEEK

You can review this product for 30 days. Your annual subscription includes published issues at no additional charge for the 12-month subscription period. 52 issues are expected. If you cancel your subscription within 30 days of receipt, you will receive a full credit upon receipt of request for cancellation.

52 weekly issues faxed by 8 a.m. every Monday morning

U.S. 12-month fax subscription: $949
Call customer service at 800-688-2421 or 404-262-5476 for international pricing

To request reprint information, contact our Special Sales Department.

For group & site license discounts, please contact a Group Sales Representative @ (800) 688-2421, ext. 5482 or click here.

 

 

Copyright Notices  | Terms of Use  
Privacy Statement